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“On” or “Off” pump coronary artery bypass grafting e Is the
last word out?O.P. Yadava*, Anirban Kundu
Department of Cardiac Surgery, National Heart Institute, New Delhi-110065, IndiaA glance at the history of the development of Coronary Artery
Bypass Surgery (CABG) throws up the interesting finding that
the first milestones were without cardiopulmonary bypass
(CPB) support. Off-pump CABG (OPCAB), having predated On-
pump surgery, has had a roller coaster ride for want of a clean,
still and bloodless field, culminating in the introduction of
CABG on CPB (On-pump) by Favaloro in 1967. This develop-
ment profoundly “democratised” the CABG procedure in that
now a broad number of surgeons could achieve better and
reproducible results with considerably more optimum oper-
ating conditions. The initial enthusiasm for On-pump CABG
gradually gave way to concerns regarding its safety, especially
with regard to complications arising from CPB, and not CABG
per se. Foremost of these relate to microembolic showering
during manipulation of the aorta and neurocognitive
dysfunction. In addition, CPB triggers a whole-body inflam-
matory response caused by contact activation of the comple-
ment cascade. This leads to multiple organ dysfunction
affecting the kidneys, liver, lungs, brain and heart itself.1
Studies published over a decade and a half ago questioned
the safety of On-pump CABG. The proportion of patients
recovering without any complication was found to be only
64.3%.2 In addition, health insurance data and data from
clinical studies showed that 10.2% did not leave the hospital
within 14 days after the operation and 3.6% of the patients
were discharged to a non-acute care facility.3 These and other
observations, pari passu with the development of mechanical
and pharmacological organ stabilizers and intracoronary
shunts, resurrected OPCAB in the early 1990s.
As regards surgical technique, the actual suture anasto-
mosis of the vessels follows the same technique both in On-
and Off-pump surgery. The difference is that unlike On-pump
surgery, where the heart is arrested by means of cardioplegia,* Corresponding author.
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the help of organ stabilizers while the anastomosis is being
performed. Pharmacologic agents like short-acting beta-
blockers (e.g. Esmolol) or Adenosine are used in conjunction
with these mechanical stabilizers to achieve the goal of a
relatively motionless field. Exposure of the heart is aided by
retraction devices like the “Starfish”, which lift up the apex
from the pericardial cavity (Table 1). Retraction can also be
achieved bymeans of folded sponges placed in the pericardial
sac to lift the heart, or by pericardial hitching sutures. Distal
coronary perfusion is maintained by means of flexible intra-
coronary shunts introduced into the coronary vessel prior to
commencement of the anastomosis (Fig. 1). Although these
devices are designed for one-time use, they may be reused
after ETO sterilization. This assumes importance as far as
cost-containment in a country like India is concerned, giving a
further fillip to Off-pump surgery.
Numerous large observational studies and small random-
ized controlled trials (RCT) have been published in the past 18
years suggesting benefits from OPCAB. Among these are, a
reduction in stroke, duration of post-operative ventilation,
need for reoperation, bleeding, wound infection, renal failure,
post-operative length of stay4 and decreased atrial fibrillation
and inotrope requirement.5 A major study published in 2001
(the Octopus trial), showing no major differences in cardiac,
neurological and neuropsychological outcomes in patients
operated On- and Off-pumpwas also a shot in the arm for Off-
pump surgery.6 However, as with any new technique, initial
enthusiasm was somewhat dampened by reports of incom-
plete revascularization using OPCAB.7 This and other reports
led to the first RCT comparing the two procedures, the Ran-
domized On/Off bypass study (ROOBY) in 2009. At 1-year of
follow-up, Off-pump patients had worse composite outcomesy of India. All rights reserved.
Table 1 e Commonly used stabilizer/retraction devices.
Name of stabilization
device
Stabilization
mechanism
Pros Cons
Medtronic-Utrecht Octopus
tissue stabilization system
Suction Good stabilization for LAD Difficulty in LCx territory,
cumbersome
(discontinued)
Octopus 1 Suction Good stabilization for LAD Bulky, cumbersome, difficulty in
LCx, long arm causes less stability;
(discontinued)
Octopus 2 Suction Better stabilization, lesser pod
height
Stiff pods may cause heart injury
(discontinued)
Octopus 3 Suction Malleable suction pods, better
adaptation to heart contour
Increased horizontal motion; (in
use)
Octopus 4 Suction 360 arm movement (in use)
Genzyme Elite stabilizer Compression of coronary
between tapes
No need for shunt Damage to coronary endothelium,
possibility of catching back wall
during anastomosis; (not widely
used)
Guidant system Suction High flexibility of arm Usable only on custom-made
retractor (in use)
Starfish positioning system Suction Allows for posterior vessel access May cause apical ischemia, injury
(in use)
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revascularization.8 The conversion rate from Off- to On-pump
procedures was 12.4%, a figure 5 times that reported in the
National Database of Thoracic Surgeons! This was bandied as
glaring evidence of the participant practitioners’ inexperi-
ence.9 The authors had addressed the prickly issue of surgeon
experience by doing a sensitivity analysis based on high vol-
ume (>50 pre-study cases) versus low volume operators, and
had found no significant difference in outcomes. Nonetheless,
many have questioned the figure of 50 cases as being insuffi-
cient to indicate surgeon experience,10 whilst disregarding
anesthesiologist experience.
As if this was not enough, another nail in the coffin of
OPCAB was driven by a recent Cochrane review meta-anal-
ysis11 from Copenhagen considering 10 low-bias trials
(n ¼ 4950) of a total of 86 RCTs comparing Off-pump with On-Fig. 1 e Diagrammatic representation of use of stabilizer & retr
Off-pump surgery. Reprinted from Verma S et al Off pump coro
cardiologist. Circulation. 2004;109:1206-1211.pump surgery, which found 30% higher risk of all-cause
mortality with Off- vs. On-pump CABG. Other adverse
events like MI, stroke, renal insufficiency or repeat revascu-
larization were similar despite a slightly lower number of
distal anastomoses Off-pump versus On-pump. In fact the
authors, Moller et al hazard to state, “findings suggest that
funding sources matter, with the device industry-funded
trials less apt to show harm from Off-pump CABG,” thereby
suggesting that vested interests may be at play. But a major
issue with the Cochrane review is that it included just one
additional study to the meta-analysis by Afilalo et al (vide
infra) which incidentally had showed clear superiority of
Off-pump CABG. This additional study, ironically of Moller
himself, had a staggering 25% mortality Off-pump, which
obviously seriously skewed the results of the review to sug-
gest harm with OPCAB.action/positioning devices and intracoronary shunts in
nary artery bypass surgery. Fundamentals for the clinical
Table 3 e CORONARY: secondary outcomes.
End point Off-pump
(%)
On-pump
(%)
HR (95% CI)
Repeat revascularization 0.7 0.2 4.01 (1.34e12.0)
Respiratory failure
or infection
5.9 7.5 0.79 (0.63e0.98)
Acute kidney injury 28.0 32.1 0.87 (0.80e0.96)
Blood transfusion 50.7 63.3 0.80 (0.75e0.85)
Reoperation for
perioperative bleeding
1.4 2.4 0.61 (0.40e0.93)
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On-pump patients 6e8 years following surgery to assess graft
patency, major adverse cardiac-related events (MACE), and
health-related quality of life. The patient cohort followed up
was from the Beating Heart Against Cardioplegic Arrest
Studies (BHACAS) 1 and 2 trials.12 Overall, 10.8% of grafts were
occluded across both groups. Further, logistic regression
analysis showed no evidence that grafts weremore likely to be
occluded in OPCAB than in On-pumppatients. The differences
in MACE-free survival and quality of Life indicators did not
approach statistical significance. Although these findings
greatly bolstered the case of the proponents of OPCAB surgery,
some shortcomings pointed out were that the modality of
assessment of graft patency was non-invasive (MDCTA) as
against the gold standard of coronary angiography; also, the
study was a single center study by a single surgical team, and
hence could not necessarily be extrapolated to other surgeons
and centers. Another concern with OPCAB is the lesser num-
ber of grafts put. But this has long been disproved by a review
of 22 RCTs which showed only 0.2 fewer grafts being put in
this group compared with On-pump.13
A meta-analysis published by Afilalo et al included
all published and unpublished RCTs of Off-pump versus
On-pump CABG from the MEDLINE, EMBASE and Cochrane
databases. It took into consideration a total of 59 trials,
encompassing 8961 patients. There was a significant 30%
reduction in post-operative strokes with Off-pump surgery
[risk ratio (RR) 0.70, 95% CI: 0.49e0.99]. There was no signifi-
cant difference in mortality (RR: 0.90, 95% CI: 0.63e1.30) or MI
(pooled RR: 0.89, 95% CI: 0.69e1.13). In the meta-regression
analysis, the effect of OPCAB on all of the clinical outcomes
was similar regardless of mean age, proportion of females in
the trial, number of grafts per patient, and trial publication
date.13
The most recent comparison study of the two techniques
is the CABG Off or On pump revascularization study (CORO-
NARY Study) published in March this year.14 The trial ran-
domized 4752 patients undergoing CABG to Off-pump or
On-pump groups. There was no significant difference seen
in the primary end-points of death, MI, stroke, or new renal
failure requiring dialysis at 30 days (Table 2).
There were, however, some differences in secondary out-
comes (Table 3), with the Off-pump group showing advan-
tages of less bleeding, respiratory infections, and acute kidney
injury, but this group also had fewer grafts performed and had
more repeat revascularizations thereby mandating longer
term follow-ups before a final verdict.Table 2 e CORONARY: primary outcomes.
Endpoint Off-pump
(%)
On-pump
(%)
HR (95% CI)
Primary composite
end point
9.8 10.3 0.95 (0.79e1.14)
Death 2.5 2.5 1.02 (0.71e1.46)
MI 6.7 7.2 0.93 (0.75e1.15)
Stroke 1.0 1.1 0.89 (0.51e1.54)
New renal failure 1.2 1.1 1.04 (0.61e1.76)The investigators thus struck a middle path by recom-
mending either of the two techniques based on patient fac-
tors, provided the surgeon was competent in both. For
example, if a patient had renal dysfunction or a heavily
calcified aorta, OPCAB would be preferred.
Much like the proverbial see-saw, a 1-year follow-up
angiographic study of the ROOBY cohort was reported this
year by Hattler at the AHA Congress in Orlando. He revealed
that Off-pump patients had a lower saphenous vein patency
than On-pump, but a similar arterial graft patency rate,
leading to less effective revascularization. Grover in an
editorial tried to reconcile the difference between the ROOBY
and CORONARY trial findings.15 The latter involved only sur-
geons experienced in Off-pump surgery, whereas the ROOBY
trial also had trainees as operating surgeons. On a conserva-
tive note however, he cautioned that any firm conclusions
would have to await long term follow-up results.
Training of surgeons in OPCAB techniques has been an
issue as it requires a great deal of focus and enthusiasm, apart
from safety concerns. However, even this issue has been laid
to rest by a recent study from the Bristol Heart Institute16 that
Off-pump surgery is not only safe and reproducible, but the
technique can be taught effectively and safely to trainees with
clinical outcomes unrelated to either the level of supervision
or the seniority of the trainees.
The final frontier for the Off-pump coronary surgeon re-
mains the patient with left main disease as well as those with
severely depressed LV function. Here too, lower mortality and
complication rates have been demonstrated.17 OPCAB has
been validated with results quite similar to the CORONARY
trial in left main stem disease also. Murzi et al showed that
OPCAB was associated with lower in-hospital mortality (0.5%
vs. 2.9%; p ¼ 0.001) and morbidity in terms of stroke, renal
dysfunction and pulmonary complications/infections.18 But
the biggest bugbear of OPCAB, viz. fewer grafts (2.7  0.7 vs.
3 0.7; p¼ 0.001) and lower rate of complete revascularization
(88.3% vs. 92%; p ¼ 0.04) continue to remain. On multivariate
analysis, CPBwas confirmed to be an independent predictor of
in-hospital mortality (OR 5.74; p ¼ 0.001). The countervailing
pros and cons negating each other lead to similar survivals at
1.5 and 10 years, a fact validated by Cheng et al.19 OPCAB has
also been shown to give superior results in patients with
chronic kidney disease.20
The International Society for Minimally Invasive Cardio-
thoracic Surgery (ISMICS) recommendations state that the use
of Off-pump bypass reduces perioperative morbidity, neuro-
cognitive dysfunction and hospital length of stay and should
be considered especially in high-risk patients, for example,
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renal insufficiency or other systemic processes that may be
exacerbated by CPB, in order to reduce morbidity and
mortality.21
A balanced approach has been advocated by the American
Heart Association in their 2011 Guidelines.22 Based on avail-
able data, the guidelines contend, both approaches are
reasonable, with certain factors tilting the balance one way or
the other. For example, the oft-quoted instance of a patient
with a heavily diseased aorta being more amenable to Off-
pump surgery. The European Guidelines (2010) on the other
hand make no mention of Off-pump surgery, stating instead
that over 70% of bypass surgeries worldwide are conducted
On-pump23 (perhaps a diplomatic way of making an undip-
lomatic point!).
As for our experience at the National Heart Institute in
Delhi of over 5000 cases done Off-pumpwith a conversion rate
of less than 1% and mortality of 1.6%, we can safely state that
this is an effective technique, provided it is adopted and
practiced in spirit as well as letter. The surgeon, and perforce
the team, should be well conversant with the nuances of Off-
pump techniques, besides being motivated, focused and in-
clined, and not be a proponent just to join the bandwagon and
be counted, whilst jeopardizing the patient’s interest. In the
end, a doctor’s reputation lives through his/her patients, and
this is no truer than for a cardiac surgeon. The best technique
is that which works best for that particular patient, in the
context of his clinical setting and his treating surgeon’s
repertoire lending credence to our strong belief that it is the
surgeon and not the technique, which is at the heart of the
problem.r e f e r e n c e s
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